Clinical lymphoma, myeloma & leukemia · 2011
A retrospective study to evaluate the work-up and follow-up of patients with monoclonal gammopathy of undetermined significance.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Berenson James R, Yellin Ori, Quiery Albert, Brady James, Patel Ravi, Wong Siu-Fun, Colbourn Donald, Gravenor Donald, Tiffany Natasha, Shamasunder H K, Waterman Benjamin, Melamed Kathryn, Wirtschafter Eric
Аннотация
BACKGROUND: Monoclonal gammopathy of undetermined significance (MGUS) is a plasma cell proliferative disorder that transforms into multiple myeloma and other serious B-cell disorders at an approximate rate of 1% per year; these patients are also at increased risk for fractures.
PATIENTS AND METHODS: We conducted a retrospective, multicenter study of 100 patients from seven community health clinics to gain a better understanding of the work-up, follow-up, and treatment of these patients.
RESULTS: MGUS patients appear to undergo inadequate work-up, follow-up, and treatment in the community setting.
CONCLUSIONS: Physicians should adhere to recently established guidelines to ensure that MGUS patients receive optimal care for this condition.
PATIENTS AND METHODS: We conducted a retrospective, multicenter study of 100 patients from seven community health clinics to gain a better understanding of the work-up, follow-up, and treatment of these patients.
RESULTS: MGUS patients appear to undergo inadequate work-up, follow-up, and treatment in the community setting.
CONCLUSIONS: Physicians should adhere to recently established guidelines to ensure that MGUS patients receive optimal care for this condition.